Germline transmission of LNKE208Q variant in a family with myeloproliferative neoplasms

American Journal of Hematology

Volumn 91, Issue 9, 2016, Pages E356-

  Loscocco, Giuseppe Gaetano ^a   Mannarelli, Carmela ^a   Pacilli, Annalisa ^a   Fanelli, Tiziana ^a,b   Rotunno, Giada ^a   Gesullo, Francesca ^a   Corbizi Fattori, Giuditta ^a,b   Vannucchi, Alessandro Maria ^a   Guglielmelli, Paola ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ASXL1 PROTEIN; CBL PROTEIN; DNA METHYLTRANSFERASE 3A; JANUS KINASE 1; JANUS KINASE 2; JANUS KINASE 3; K RAS PROTEIN; LNK PROTEIN; LNKE208Q PROTEIN; NFE2 PROTEIN; NRAS PROTEIN; PROTEIN; SF3B1 PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 2; SUPPRESSOR OF CYTOKINE SIGNALING 3; TET2 PROTEIN; TRANSCRIPTION FACTOR EZH2; U2AF1 PROTEIN; UNCLASSIFIED DRUG;

ALLELE; CELL PROLIFERATION; CODON; EXON; GEL ELECTROPHORESIS; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; GERMLINE MUTATION; HUMAN; LETTER; MYELOPROLIFERATIVE NEOPLASM; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84983084902     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.24437     Document Type: Letter

References (6)

1. Saliba J, Saint-Martin C, Di Stefano A, et al. Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies. Nat Genet 2015;47:1131–1140.
2. Jager R, Harutyunyan AS, Rumi E, et al. Common germline variation at the TERT locus contributes to familial clustering of myeloproliferative neoplasms. Am J Hematol 2014;89:1107–1110.
3. Spolverini A, Pieri L, Guglielmelli P, et al. Infrequent occurrence of mutations in the PH domain of LNK in patients with JAK2 mutation-negative ‘idiopathic’ erythrocytosis. Haematologica 2013;98:e101–e102.
4. Oh ST, Simonds EF, Jones C, et al. Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms. Blood 2010;116:988–992.
5. McMullin MF, Cario H. LNK mutations and myeloproliferative disorders. Am J Hematol 2016;91:248–251.
6. Tapper W, Jones AV, Kralovics R, et al. Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms. Nat Commun 2015;6:6691.